Verici Dx (LON:VRCI) Trading 14.1% Higher – Should You Buy?

Verici Dx plc (LON:VRCI)’s share price shot up 14.1% during trading on Tuesday . The stock traded as high as GBX 4.92 ($0.06) and last traded at GBX 4.85 ($0.06). 235,418 shares traded hands during trading, a decline of 33% from the average session volume of 350,158 shares. The stock had previously closed at GBX 4.25 ($0.05).

Verici Dx Trading Up 4.3 %

The stock has a market cap of £14.55 million, a P/E ratio of -300.00 and a beta of 1.59. The company has a current ratio of 4.54, a quick ratio of 8.49 and a debt-to-equity ratio of 4.65. The stock’s fifty day moving average price is GBX 3.21 and its 200 day moving average price is GBX 5.27.

Verici Dx Company Profile

Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.